FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2077762392> ?p ?o ?g. }

• W2077762392 endingPage "161.e2" @default.
• W2077762392 startingPage "155" @default.
• W2077762392 abstract "To determine the aqueous levels of vascular endothelial growth factor (VEGF) in patients with type 3 neovascularization (NV) secondary to age-related macular degeneration (AMD) and to compare the levels of those with type 1 and 2 NV secondary to AMD before and after administration of intravitreal bevacizumab (IVB).Prospective, case-control study.Aqueous samples were collected from 29 eyes of 29 patients with untreated wet AMD at baseline (day of the first IVB), month 1 (day of the second IVB), and month 2 (day of the third IVB). Among them, 10 eyes presented with type 1, 9 with type 2, and 10 with type 3 NV. A group of 14 aqueous samples from 14 patients who underwent cataract surgery without other ocular or systemic disease comprised the controls. Main outcome measures were concentration of VEGF at baseline and after IVB in the 3 NV groups; secondary outcome measures included best-corrected visual acuity (BCVA) and central macular thickness (CMT) changes after IVB. Levels of VEGF were determined by commercially available enzyme-linked immunosorbent assay kits.VEGF concentrations in aqueous humor at baseline were higher in patients with type 3 NV when compared to controls (P = .0001) and type 1 and 2 NV patients (P = .002 and P = .0001 respectively). At month 1, levels of VEGF were significantly reduced compared to baseline (P < .05) and significantly lower compared to the controls (P < .005) in each NV group. These low levels were maintained at the 2-month interval. BCVA significantly improved in type 1 and 2 NV groups (P < .05). CMT significantly reduced in each NV group compared to baseline (P < .05).In eyes with untreated wet AMD, aqueous levels of VEGF are significantly higher in type 3 NV than in type 1 or 2 NV. Regardless of the type of NV, aqueous VEGF levels significantly reduce 1 month after IVB as compared to both the baseline measurements and the values recorded in age-matched controls. These decreases are maintained at 2 months after administering a second IVB 30 days after the initial injection." @default.
• W2077762392 created "2016-06-24" @default.
• W2077762392 creator A5018266205 @default.
• W2077762392 creator A5023102332 @default.
• W2077762392 creator A5048632760 @default.
• W2077762392 creator A5050238811 @default.
• W2077762392 creator A5053469114 @default.
• W2077762392 creator A5054144013 @default.
• W2077762392 creator A5055286766 @default.
• W2077762392 creator A5086067624 @default.
• W2077762392 date "2012-01-01" @default.
• W2077762392 modified "2023-10-18" @default.
• W2077762392 title "Aqueous Humor Levels of Vascular Endothelial Growth Factor Before and After Intravitreal Bevacizumab in Type 3 Versus Type 1 and 2 Neovascularization. A Prospective, Case-Control Study" @default.
• W2077762392 cites W1731074416 @default.
• W2077762392 cites W1967725597 @default.
• W2077762392 cites W1970699493 @default.
• W2077762392 cites W1981427921 @default.
• W2077762392 cites W1983308284 @default.
• W2077762392 cites W1988513599 @default.
• W2077762392 cites W1988711529 @default.
• W2077762392 cites W1990850867 @default.
• W2077762392 cites W1999053742 @default.
• W2077762392 cites W1999946691 @default.
• W2077762392 cites W2001427301 @default.
• W2077762392 cites W2001825182 @default.
• W2077762392 cites W2005795041 @default.
• W2077762392 cites W2009758003 @default.
• W2077762392 cites W2016965931 @default.
• W2077762392 cites W2025214768 @default.
• W2077762392 cites W2041985399 @default.
• W2077762392 cites W2042088079 @default.
• W2077762392 cites W2045317893 @default.
• W2077762392 cites W2051149451 @default.
• W2077762392 cites W2062886219 @default.
• W2077762392 cites W2064892180 @default.
• W2077762392 cites W2069853487 @default.
• W2077762392 cites W2075677316 @default.
• W2077762392 cites W2078993435 @default.
• W2077762392 cites W2086643599 @default.
• W2077762392 cites W2087650196 @default.
• W2077762392 cites W2088804885 @default.
• W2077762392 cites W2092513931 @default.
• W2077762392 cites W2096600613 @default.
• W2077762392 cites W2127203013 @default.
• W2077762392 cites W2135712099 @default.
• W2077762392 cites W2137893922 @default.
• W2077762392 cites W2146587653 @default.
• W2077762392 cites W2163616867 @default.
• W2077762392 cites W2324588265 @default.
• W2077762392 cites W2325448373 @default.
• W2077762392 cites W2325901584 @default.
• W2077762392 cites W2327207950 @default.
• W2077762392 cites W4233657213 @default.
• W2077762392 cites W4251857773 @default.
• W2077762392 doi "https://doi.org/10.1016/j.ajo.2011.06.001" @default.
• W2077762392 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21861975" @default.
• W2077762392 hasPublicationYear "2012" @default.
• W2077762392 type Work @default.
• W2077762392 sameAs 2077762392 @default.
• W2077762392 citedByCount "34" @default.
• W2077762392 countsByYear W20777623922012 @default.
• W2077762392 countsByYear W20777623922013 @default.
• W2077762392 countsByYear W20777623922014 @default.
• W2077762392 countsByYear W20777623922015 @default.
• W2077762392 countsByYear W20777623922016 @default.
• W2077762392 countsByYear W20777623922017 @default.
• W2077762392 countsByYear W20777623922018 @default.
• W2077762392 countsByYear W20777623922019 @default.
• W2077762392 countsByYear W20777623922020 @default.
• W2077762392 countsByYear W20777623922021 @default.
• W2077762392 countsByYear W20777623922022 @default.
• W2077762392 crossrefType "journal-article" @default.
• W2077762392 hasAuthorship W2077762392A5018266205 @default.
• W2077762392 hasAuthorship W2077762392A5023102332 @default.
• W2077762392 hasAuthorship W2077762392A5048632760 @default.
• W2077762392 hasAuthorship W2077762392A5050238811 @default.
• W2077762392 hasAuthorship W2077762392A5053469114 @default.
• W2077762392 hasAuthorship W2077762392A5054144013 @default.
• W2077762392 hasAuthorship W2077762392A5055286766 @default.
• W2077762392 hasAuthorship W2077762392A5086067624 @default.
• W2077762392 hasConcept C118487528 @default.
• W2077762392 hasConcept C126322002 @default.
• W2077762392 hasConcept C126894567 @default.
• W2077762392 hasConcept C134018914 @default.
• W2077762392 hasConcept C141071460 @default.
• W2077762392 hasConcept C167734588 @default.
• W2077762392 hasConcept C188816634 @default.
• W2077762392 hasConcept C2776403814 @default.
• W2077762392 hasConcept C2776694085 @default.
• W2077762392 hasConcept C2777025900 @default.
• W2077762392 hasConcept C2777802072 @default.
• W2077762392 hasConcept C2778257484 @default.
• W2077762392 hasConcept C2778271429 @default.
• W2077762392 hasConcept C2779829184 @default.
• W2077762392 hasConcept C2780394083 @default.
• W2077762392 hasConcept C2781100027 @default.
• W2077762392 hasConcept C2781359195 @default.
• W2077762392 hasConcept C2993390227 @default.

• next